Key facts
| Price (PPV) | 71.50 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | enalaprilhydrochlorothiazide |
| Class | Agents acting on the renin-angiotensin system |
| ATC code | C09BA02 |
| Manufacturer | ATLAS PHARM |
| Presentation | Boîte de 30 |
| Nature | Médicament |
| Hospital price | 44.70 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement de l'hypertension artérielle en cas d'échec thérapeutique d'une monothérapie par un inhibiteur de l'enzyme de conversion.
Find an open pharmacy
On-call pharmacies near you
About Hypril 20 mg / 12.5 mg
Hypril 20 mg / 12.5 mg belongs to the agents acting on the renin-angiotensin system therapeutic class. In Morocco, this drug is marketed by ATLAS PHARM and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Hypril 20 mg / 12.5 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Hypril 20 mg / 12.5 mg
Answers to common questions from Moroccan patients about this drug.